Analyst
Purpurchity Ventures
Equibles does not estimate personal net worth.
Ishika is recorded as Analyst at Purpurchity Ventures. Ishika has spoken on 1 earnings call across 1 company, most recently for Marksans Pharma Limited on February 6, 2026. The companies whose calls Ishika spoke on are classified in the Healthcare sector.
“The cash from the books is around 824 CR. Is this just in India or is this placed in any subsidiaries in US or UK as well?”
Purpurchity Ventures
Analyst
Transcript header (unverified)
Marksans Pharma Limited
Drug Manufacturers - General · Healthcare
“Marksans Pharma Limited Q3 FY26 Earnings Conference Call”
Marksans Pharma Limited
